These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
520 related articles for article (PubMed ID: 17143333)
1. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333 [TBL] [Abstract][Full Text] [Related]
2. Proinsulin: a unique autoantigen triggering autoimmune diabetes. You S; Chatenoud L J Clin Invest; 2006 Dec; 116(12):3108-10. PubMed ID: 17143326 [TBL] [Abstract][Full Text] [Related]
3. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men. Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840 [TBL] [Abstract][Full Text] [Related]
4. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087 [TBL] [Abstract][Full Text] [Related]
5. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes. Kishi M; Yasuda H; Abe Y; Sasaki H; Shimizu M; Arai T; Okumachi Y; Moriyama H; Hara K; Yokono K; Nagata M Biochem Biophys Res Commun; 2010 Mar; 394(1):228-32. PubMed ID: 20206130 [TBL] [Abstract][Full Text] [Related]
6. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes. Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527 [TBL] [Abstract][Full Text] [Related]
7. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes. Serreze DV; Marron MP; Dilorenzo TP Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821 [TBL] [Abstract][Full Text] [Related]
8. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094 [TBL] [Abstract][Full Text] [Related]
9. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. Han B; Serra P; Yamanouchi J; Amrani A; Elliott JF; Dickie P; Dilorenzo TP; Santamaria P J Clin Invest; 2005 Jul; 115(7):1879-87. PubMed ID: 15937548 [TBL] [Abstract][Full Text] [Related]
10. Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD mice. Martinic MM; Juedes AE; Bresson D; Homann D; Skak K; Huber C; Ling E; Ejrnaes M; Wolfe T; Togher L; Christen U; von Herrath MG Diabetes; 2007 Apr; 56(4):1059-68. PubMed ID: 17395746 [TBL] [Abstract][Full Text] [Related]
11. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140 [TBL] [Abstract][Full Text] [Related]
12. Autoantigen recognition is required for recruitment of IGRP(206-214)-autoreactive CD8+ T cells but is dispensable for tolerance. Wang J; Tsai S; Han B; Tailor P; Santamaria P J Immunol; 2012 Sep; 189(6):2975-84. PubMed ID: 22908330 [TBL] [Abstract][Full Text] [Related]
13. Genetic and therapeutic control of diabetogenic CD8+ T cells. Santamaria P Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463 [TBL] [Abstract][Full Text] [Related]
14. Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic mice. Krishnamurthy B; Mariana L; Gellert SA; Colman PG; Harrison LC; Lew AM; Santamaria P; Thomas HE; Kay TW J Immunol; 2008 Apr; 180(7):4458-64. PubMed ID: 18354167 [TBL] [Abstract][Full Text] [Related]
15. Long-range enhancers are required to maintain expression of the autoantigen islet-specific glucose-6-phosphatase catalytic subunit-related protein in adult mouse islets in vivo. Wang Y; Flemming BP; Martin CC; Allen SR; Walters J; Oeser JK; Hutton JC; O'Brien RM Diabetes; 2008 Jan; 57(1):133-41. PubMed ID: 17942825 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma. Zwicker K; Chatten C; Gratton K; Demetrick D; Serra P; Shameli A; Santamaria P; Bathe OF J Immunol; 2009 Aug; 183(3):1705-14. PubMed ID: 19570832 [TBL] [Abstract][Full Text] [Related]
18. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct. Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704 [TBL] [Abstract][Full Text] [Related]
19. A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes. Hutton JC; Eisenbarth GS Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8626-8. PubMed ID: 12861077 [No Abstract] [Full Text] [Related]